EMA establishes Cancer Medicines Forum with academia to optimise cancer treatments in clinical practice
8. April 2022 – EMA, in collaboration with the European Organisation for Research and Treatment of Cancer (EORTC), has launched the Cancer Medicines Forum (CMF). Bringing together representatives from academic organisations and the European medicines regulatory network, the forum aims at advancing research into optimising cancer treatments and will contribute to foster high standards in cancer care in the European Union (EU).
For more information, see here.